{
    "title": "FDA set to approve a new Alzheimer's drug - a first in nearly 20 years - by March after Biogen showed its treatment may slow the progress of the memory disease",
    "url": "https://www.dailymail.co.uk/health/article-8914057/Biogen-Alzheimers-drug-gets-U-S-FDA-staffs-backing-ahead-approval-meeting.html",
    "date": "2020-11-04",
    "keywords": [
        "drug",
        "approval",
        "aducanumab",
        "biogen",
        "evidence",
        "fda",
        "staff",
        "treatment",
        "trial",
        "study",
        "company",
        "tau",
        "disease",
        "percent",
        "analyst",
        "dementia",
        "share",
        "analysis",
        "food",
        "administration",
        "time",
        "wednesdaybiogen",
        "swift",
        "presence",
        "protein",
        "march",
        "progression",
        "mindwasting",
        "condition",
        "partner",
        "rise",
        "lily",
        "co",
        "meeting",
        "friday",
        "antibody",
        "brainbriefing",
        "committee",
        "vote",
        "yatin",
        "suneja",
        "research",
        "note",
        "mizuho",
        "bestcase",
        "scenario",
        "water",
        "swimming",
        "article",
        "panel",
        "reviewer",
        "effect",
        "staffer",
        "tristan",
        "massie",
        "firm",
        "advocacy",
        "needif",
        "access",
        "howard",
        "fillit",
        "science",
        "officer",
        "discovery",
        "foundationbiogen",
        "patent",
        "fight",
        "tecfidera",
        "refinitivcambridge",
        "october",
        "year",
        "futility",
        "course",
        "dose",
        "effectiveness",
        "eisai"
    ],
    "category": [
        "health"
    ]
}